Research Use Only. Not for use with diagnostic procedures.
AVENIO is a trademark of Roche.
Next-generation sequencing (NGS) is driving advances in life sciences, translational and clinical research. From expanding our understanding of cancer, reproductive and developmental biology to unravelling complex microbial populations, NGS is touching all facets of human disease and wellbeing.
The NGS workflow is a multi-step process consisting of three main stages, namely sample preparation, sequencing, and data analysis/reporting. Over the past few years, Roche Sequencing Solutions has made significant investments in best-in-class technologies in all three areas, and are working towards integrating these into validated, end-to-end solutions. Explore our portfolio of high quality NGS solutions to find out how you can maximize the value of your NGS samples and sequencing projects.
As the first step in the NGS workflow continuum, sample prep holds the key to unlocking the potential of every sample. Explore our integrated Roche Sample Prep Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, complete and simple.
AVENIO Tumor Tissue Analysis Kits Three NGS pan-cancer assays for comprehensive genomic profiling of DNA in formalin-fixed paraffin-embedded (FFPE) tissue sample
AVENIO ctDNA Analysis Kits Three NGS pan-cancer liquid biopsy assays for non-invasive profiling and monitoring of cell-free DNA derived from solid tumors
